JAMES GERAGHTY – “INSIDE THE ORPHAN DRUG REVOLUTION” – 12 31 22

JAMES GERAGHTY – “INSIDE THE ORPHAN DRUG REVOLUTION” – 12 31 22

Imagine facing a disease so rare that even doctors struggle to recognize it. In this episode of 'American Medicine Today', hosts Kimberly Bermel Benati and Ethan Uecker sit down with James Geraghty, author of 'Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology'. They explore the often-overlooked world of rare diseases and the groundbreaking advancements in biotechnology aimed at treating them.

Geraghty dives into the story of Henry Jermier, an entrepreneur who defied the odds to develop a successful therapy for Gaucher disease, a condition first identified over a century ago in France. Despite initial skepticism from investors, Jermier's perseverance paid off, revolutionizing treatment options for those suffering from orphan diseases. Geraghty highlights the challenges in diagnosing and treating these rare conditions, which collectively impact nearly one-tenth of the U.S. population.

He also discusses the urgent need for regulatory reforms to expedite the approval process for these life-saving drugs and the potential of genetic therapies to offer long-term benefits. This episode is a beacon of hope for anyone affected by rare diseases, showcasing how innovation and determination can lead to medical breakthroughs. Tune in for an enlightening conversation that underscores the importance of continued investment and support in the field of rare disease treatment.